-+ 0.00%
-+ 0.00%
-+ 0.00%

Celldex Launches Phase 3 Trial of Barzolvolimab for Cold Urticaria and Symptomatic Dermographism

Reuters·12/09/2025 13:01:42

Please log in to view news